NASDAQ: IONSIonis Pharmaceuticals Inc Stock Ownership - Who owns Ionis Pharmaceuticals?
Insider buying vs selling
Have Ionis Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael R. Hayden | Director | 2025-05-01 | 15,000 | $31.86 | $477.90kBuy |
| Joseph Baroldi | EVP Chief Business Officer | 2025-04-16 | 3,928 | $28.40 | $111.56kSell |
| Kyle Jenne | EVP Chf GL Pdt Str Ofcr | 2025-04-16 | 3,016 | $28.36 | $85.53kSell |
| Brian Birchler | EVP Corp and Development Ops | 2025-04-16 | 680 | $28.37 | $19.29kSell |
| Brett P. Monia | Chief Executive Officer | 2025-03-11 | 140 | $32.32 | $4.52kSell |
| Eric Swayze | EVP Research | 2025-02-28 | 415 | $28.21 | $11.71kBuy |
| C. Frank Bennett | EVP Chief Scientific Officer | 2025-02-28 | 320 | $28.21 | $9.03kBuy |
| Patrick R. Oneil | EVP CLO General Counsel | 2025-02-28 | 554 | $28.21 | $15.63kBuy |
| Brian Birchler | EVP Corp and Development Ops | 2025-02-28 | 414 | $28.21 | $11.68kBuy |
| Richard S. Geary | EVP Chief Development Officer | 2025-02-28 | 415 | $28.21 | $11.71kBuy |
IONS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IONS insiders and whales buy or sell their stock.
IONS Shareholders
What type of owners hold Ionis Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 14.84% | 23,613,585 | $939.82M | Institution |
| Vanguard Group Inc | 10.29% | 16,383,934 | $652.08M | Institution |
| T Rowe Price Investment Management Inc | 10.16% | 16,175,533 | $643.79M | Institution |
| Capital World Investors | 7.77% | 12,361,994 | $492.01M | Institution |
| Blackrock Inc | 7.08% | 11,264,442 | $448.32M | Institution |
| Wellington Management Group LLP | 5.29% | 8,416,421 | $334.97M | Institution |
| Bellevue Group Ag | 4.93% | 7,853,198 | $312.56M | Institution |
| State Street Corp | 3.04% | 4,845,133 | $192.84M | Institution |
| Deep Track Capital LP | 2.87% | 4,564,207 | $181.66M | Institution |
| Citadel Advisors LLC | 2.19% | 3,480,062 | $138.51M | Institution |
IONS vs Biotech Stocks
Ionis Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.